123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: Paradoxical positivity in an oncocytic adrenocortical carcinoma [123I-Methyljodbenzylguanidin- (MIBG-) szintigraphie: Paradoxe nuklidspeicherung eines onkozytären nebennierenrindenkarzinoms]

被引：0
作者：
Padberg B.-C. [1 ,6 ]
Rordorf T. [2 ]
Suter S.L. [3 ]
Pfeiffer D. [1 ]
Wild D. [4 ]
Schröder S. [5 ]
机构：
[1] Institut für Klinische Pathologie, Universitätsspital, Zürich
[2] Abt. Onkologie, Medizinische Klinik A, Universitätsspital Zürich
[3] Praxis für Innere Medizin (Endokrinologie), Zürich
[4] Klinik für Nuklearmedizin, Universitätsspital Zürich
[5] Gemeinschaftspraxis für Pathologie, Hamburg
[6] Institut für Klinische Pathologie, Universitätsspital, 8091 Zürich
来源：
Der Pathologe | 2007年 / 28卷 / 4期
关键词：
!sup]123[!/sup]I-metaiodobenzylguanidine (MIBG); Adrenal cortical carcinoma; Adrenal gland; Histology; Pheochromocytoma;
D O I：
10.1007/s00292-006-0832-3
中图分类号：
学科分类号：
摘要：
123I-metaiodobenzylguanidine (MIBG), a radio-labeled catecholamine analogue, is used for the imaging of pheochromocytoma based on the selective uptake of MIBG by chromaffin tissues. MIBG scintigraphy displays high sensitivity (90%) and specificity (close to 100%). In contrast, the false-positive uptake of MIBG by adrenal cortical carcinoma is rare. Here, we report a metastatic oncocytic adrenal cortical carcinoma with MIBG uptake used for therapeutic purposes. © 2007 Springer Medizin Verlag.
引用
收藏
页码：281 / 284
页数：3
相关论文
共 22 条
  • [1] Alsabeh, Am J Clin Pathol, 104, (1995)
  • [2] Bathmann, Clin Nucl Med, 19, (1994)
  • [3] Burak, New York J Med, 59, (1959)
  • [4] El-Naggar, Ultrastruct Pathol, 15, (1991)
  • [5] Hoang, Mod Pathol, 15, (2002)
  • [6] Horne, Clin Nucl Med, 16, (1991)
  • [7] Houghton, Br J Clin Pract, 44, (1990)
  • [8] Jakobs, Clin Nucl Med, 15, (1990)
  • [9] Kek, Exp Clin Endocrinol Diabetes, 111, (2003)
  • [10] Komminoth, Lab Invest, 72, (1995)
123